The cecostomy button.

P G Chait; B Shandling; H F Richards

doi:10.1016/s0022-3468(97)90634-5

Home/Archive/PubMed

PubMed · 9200084

The cecostomy button.

P G Chait·B Shandling·H F Richards

View original source ↗Export metadata ↓

Abstract

Percutaneous insertion of a cecostomy tube, performed under local anesthesia, to facilitate antegrade colonic cleansing, has been an invaluable advance in the management of fecal incontinence. However, the patient is left with a length of tubing (2 to 4 inches) protruding from the cecostomy site that has to be taped down to the abdominal wall. Available devices for insertion in place of the cecostomy tube are cumbersome and have a relatively high profile, projecting more than 1 cm from the surface of the abdominal wall. Worn under a swimsuit, they are clearly discernible. The inflated balloon within the cecum can occasionally break. Furthermore, in the individual with a relatively thick abdominal wall, such devices are too short to reach from the skin to the cecum. A new form of low-profile trapdoor device has been developed that overcomes the above shortcomings of other available "buttons." It has been successfully used in a clinical setting in 49 patients.

Explore related subjects

Catheters, Indwelling Cecostomy Child Equipment Design Fecal Incontinence Humans Quality of Life Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

P G Chait, B Shandling, H F Richards. 1997. The cecostomy button.. https://doi.org/10.1016/s0022-3468(97)90634-5

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1999

The use of pleuroperitoneal shunts in the management of persistent chylothorax in infants.

BACKGROUND/PURPOSE: The development of chylothorax is a serious and often life-threatening clinical entity that may cause profound respiratory, nutritional, and immunologic complications and has become increasingly common in recent years. Optimal management of this problem has not been well defined because medical therapy has a significant failure rate. Surgical treatment of complicated chylothorax has become a mainstay of care. METHODS: Over the last 36 months, seven infants had a pleuroperitoneal shunt placed for the management of refractory chylothorax. Ages ranged from 10 to 66 days with a weight between 1,000 to 4,850 g. Five of the seven infants were ventilator dependent. The etiologies were congenital in four and acquired in three with one related to a cardiothoracic procedure, one related to superior vena caval thrombosis, and one postoperative diaphragmatic hernia repair with superior vena caval thrombosis. Associated conditions included a left congenital diaphragmatic hernia, asplenia, isolated renal agenesis, bronchopulmonary dysplasia, and a patent ductus arteriosus. Each patient was unresponsive to thoracentesis, tube thoracostomy, and dietary manipulation with preoperative volume of chest tube output ranging from 50 to 162 cc/kg/d. The duration of preoperative therapy in congenital occurrences ranged from 10 to 46 days (average, 22 days). A Denver double-valved shunt system was used and catheters were implanted under general anesthesia. Manual pumping was required postoperatively on an hourly basis. RESULTS: All seven patients had excellent results with the elimination of the chylothorax and resolution of symptoms. There were two complications. Shunt survival rate was six of seven (86%). Shunt removal ranged from 24 to 79 days (average, 44 days). Patient survival rate was five of seven (71%) with one infant dying of progressive pulmonary disease and one infant dying from viral sepsis; both had functioning shunts. One patient remains ventilator dependent secondary to chronic lung disease from prematurity. CONCLUSIONS: Pleuroperitoneal shunting is safe, simple, and an effective treatment of chylothorax in infants despite their size, age, or degree of prematurity.

Catheters, Indwelling↗

PubMed1999

Implementation of the Dialysis Outcomes Quality Initiative Vascular Access Guidelines.

To better care for patients with chronic renal failure and end-stage renal disease, the National Kidney Foundation has published a set of Clinical Guidelines, the Dialysis Outcomes Quality Initiative, based on current available evidence and, where such evidence is lacking, the expert opinions of current leaders in vascular access research. These Guidelines were developed to standardize the care of chronic renal failure and end-stage renal disease patients. This report describes some of the more important aspects of these recommendations and the authors' implementation strategies.

Catheters, Indwelling↗

PubMed1999

Optimizing vascular access: a team perspective using the National Kidney Foundation-Dialysis Outcomes Quality Initiative Guidelines.

The implementation of the Dialysis Outcomes Quality Initiative (DOQI) Vascular Access Guidelines can appear as an overwhelming task. This article suggests very basic and practical actions the entire end-stage renal disease (ESRD) team can take to help put the DOQI Guidelines into every day practice. The simple format of an early prerenal education program may help increase the number of native arterio-venous fistula placed in new ESRD patients. The focus is on the ESRD team working together to remove common barriers preventing the implementation of the DOQI Guidelines. Examples about the role the social worker and renal dietitian can fulfill as part of the Guideline implementation are presented. This article is based on previous personal work experience as a member of the ESRD Team and as a Work Group Member.

Catheters, Indwelling↗